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Abstract 
 
Background: The aim was to study the association between allergic multimorbidity and adult-onset 
asthma considering the number of allergic diseases and the age effect. 
 
Methods: We used population-based data from Finnish national registers including 1205 adults over 
30 years of age with recently diagnosed asthma (age range: 30-93), matched for gender, age, and 
living region with one or two controls (n=2050). Allergic rhinitis (AR), allergic conjunctivitis (AC) and 
allergic dermatitis (AD), was defined from self-completed questionnaire. Conditional logistic 
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regression adjusted on potential confounders (smoking, growing in countryside, childhood 
hospitalized infection/pneumonia, parental asthma/allergy, parental smoking, education level, 
professional training, number of siblings, and birth order) was applied to estimate the asthma risk 
associated with allergic multimorbidity.  
 
Results: 1118 cases with asthma and 1772 matched controls were included [mean (sd, min-max) 53 
(11, 31-71) years, 37 % men)]. AR, AC or AD were reported by 50.2 %, 39.6 %, 33.8 %, respectively 
among subjects with asthma and 26.1 %, 20.0 %, 23.5 %, among controls. Compared to non-atopics, 
adult-onset asthma increased with the number of allergic diseases; adjusted OR for asthma [CI95%] 
associated with 1, 2, and 3 allergic diseases were 1.95 [1.52-2.49], 2.87 [2.19-3.77], and 4.26 [3.07-
5.90], respectively. The association between adult-onset asthma and ≥1 allergic multimorbidity 
decreased with increasing age (3.52 [2.51-4.94], 2.44 [1.74-3.42] and 1.68 [1.04-2.71]) in subjects 
<50 years, 50-62 years and >62 years, respectively (p for age*≥1 allergic multimorbidity interaction, 
.002). 
 
Conclusions: Adult-onset asthma was positively associated with the number of allergic diseases and 
this association decreases with age. 
 
Key words 
 asthma, atopic dermatitis, epidemiology, ocular allergy, rhinitis. 
 
Short title 
Allergic multimorbidity is associated with an increased risk of asthma in adults 
 
Total word count:  
 
Abbreviations 
AC = allergic conjunctivitis 
AD = allergic dermatitis 
AR = allergic rhinitis  
CI = confidence interval 
FEV1 = forced expiratory volume during the first second  
OR = odds ratio 
PEF = peak expiratory flow 
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SII = Social Insurance Institution of Finland 
 
Background 
 
The prevalence of allergic diseases, including asthma, rhinitis, atopic dermatitis and food allergy, 
critically increased across the world over the past decades. Asthma, a common non-communicable 
disease, is a major public health issue, with over 300 million people affected worldwide (1,2). In 
children, several cohort studies showed that allergic diseases were associated with increased risk of 
asthma (3,4). A study of German children showed that asthma occurs in both sexes more frequently 
with coexisting allergies than as a single entity (4). In a secondary pediatric outpatient clinic, allergic 
conjunctivitis was a frequent co-morbidity to allergic rhinitis and to asthma and eczema (5).  
 
Compared to pediatric population, less studies exist on the role of allergic diseases in asthma among 
adult population, and most of the studies only considered rhinitis. A study of a European adult 
population detected strong association between perennial rhinitis and asthma in nonatopic subjects 
(6). A nested case-control study from a cohort in a Tucson population showed that rhinitis was a 
significant risk factor for late-onset asthma in both atopic and nonatopic subjects (7). A Finnish 
population-based study found that allergic rhinoconjunctivitis doubles the risk for incident asthma 
(8). Further comprehensive studies simultaneously considering allergic rhinitis, allergic dermatitis 
and conjunctivitis are needed to have a better insight on the role of allergic multimorbidity on adult-
onset asthma.   
 
Only few previous studies have addressed cohort- or age effect of the co-existing allergic diseases 
and asthma. It has been shown that the prevalence of allergic asthma has increased from 1996 to 
2006 and further to 2016, while the prevalence of non-allergic asthma has remained stable (9). We 
have found that polysensitization was associated with asthma in adults (10,11), and polysensitization 
and its asthma-risk increases in adults who were born after 1930 proposing a cohort and/or age 
affect between polysensitization and asthma in adults (12). 
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Early detection and prevention of allergic multimorbidity that persists in adulthood could putatively 
reduce asthma burden in adults. As there is still limited knowledge of the putative causal effect 
between allergic multimorbidity and asthma in adults, the aim was to assess the association 
between allergic multimorbidity and adult-onset asthma in a large population-based case control 
study on asthma, the Adult Asthma in Finland (13). We hypothesized that each allergic disease, AR, 
AD and AC, is positively associated with adult-onset asthma and that the asthma risk increases with 
the number of allergic multimorbidities. Our secondary hypothesis was that the asthma risk 
associated with allergic multimobidity increases with younger age.    
 
Methods 
 
Study design 
This is a cross-sectional population-based case-control study of adult-onset asthma in Finland. We 
used a questionnaire of childhood and adulthood factors in 1996-97. 
 
Setting  
Population-based sample of asthmatics of Finland and their matched controls. 
 
Study Population  
The Adult Asthma in Finland is a population-based matched case control study conducted in 1997 
(Figure 1) as previously described (13,14). This study collected information from 1400 asthma 
patients older than 30 years of age with a recent asthma diagnosis (<1 year). The asthmatics formed 
a random sample drawn from the Finnish Drug Reimbursement register, maintained by Social 
Insurance Institution (SII) of Finland, in which all newly diagnosed cases in the study population 
could be identified by the asthma drug reimbursement decision of diagnosed asthma. In detail, the 
reimbursement right is granted by certificate that has been made by patient´s physician. This 
certificate has to include background information, clinical exam´s results, lung function test results 
as well as findings and conclusions after asthma treatment test period of 6 months. These 
certificates are reviewed case by case by SII´s physician, who gives the reimbursement right.  SII 
stores the certificates, in which the lung functions test results are referred. Lung function test 
parameters are not stored by SII as variable data, yet this data are stored by the patient´s hospital. 
All asthmatics fulfilled the following criteria for doctor-diagnosed asthma in this register: typical 
history, clinical features, and asthma course, at least one of the following physiologic criteria: (i) a 
variation of 20% or greater in diurnal peak expiratory flow (PEF) recording (reference to maximal 
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value); (ii) an increase of 15% or greater in PEF or forced expiratory volume in 1 second (FEV1) with 
b-agonist; or (iii) an decrease of 15% or greater in PEF or FEV1 in exercise testing. This method of 
case ascertainment has been validated earlier (15,16). The asthmatics were matched for gender, age 
(±2 years), and living region (area of residence by postal code) with two controls drawn from 
National Registers, through Mini Finland Health Survey, and through a population register (Figure 1) 
(13). Questionnaire consisted of demographic questions (for both groups), and asthma-specific 
questions for asthma patients. The proportion of the responders in asthma and control group was 
86.1% and 73.2%, correspondingly. Approval for the study was obtained from the ethical committee 
at Tampere University Hospital and a written consent was obtained from all subjects. Selected 
controls did not have in 1997 a valid decision for drug reimbursement of diagnosed asthma in the 
Drug Reimbursement register. To make sure that the controls did not have accidentally an asthma, 
and that cases had asthma, all subjects were asked doctor-diagnosed asthma and current asthma 
medication, and asthmatics were additionally asked age at onset of asthma symptoms, the place of 
physician-diagnosed asthma and severity of asthma symptoms. We found that only 1.4 % of the 
controls responded that they have a doctor diagnosed asthma with current asthma medication, and 
0.9 % of the asthmatics responded that they do not have (Table 1). 
 
Outcomes 
Definition of adult-onset asthma and severe asthma 
All asthmatics fulfilled the following criteria for asthma: typical history, clinical features, and asthma 
course; at least one of the following physiologic criteria: (i) a variation of 20 % or greater in diurnal 
peak expiratory flow (PEF) recording (reference to maximal value); (ii) an increase of 15% or greater 
in PEF or forced expiratory volume in 1 sec (FEV1) with β-agonist; or (iii) an decrease of 15% or 
greater in PEF or FEV1 in exercise testing. This method of case ascertainment has been validated 
earlier (15,16). The responders were asked the year of doctor-diagnosed asthma. The (mean±SD) age 
of doctor-diagnosed asthma was 48.8±12.7 years. All responders were asked whether they have had 
cough/dyspnea with wheeze ever (Table 1). The asthmatics were asked age at asthma onset, 
severity of asthma symptoms, and the place of physician-diagnosed asthma (Table 1).  
 
Severe asthma was defined as self-reported severe asthma symptoms AND regular impairment 
caused by asthma AND (≥1 oral corticosteroid course/regular oral corticosteroids due to asthma 
during the past 12 months AND/OR wake up in the night due to asthma ≥1/week). 
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Definition of allergic multimorbidity 
AR was asked by the question ‘Have you ever had hay fever or other rhinitis symptoms that are 
related to pollens or animals?’ (No, Yes, Don´t know). AC and AD were asked “Do you get any other 
allergic symptoms? Skin symptoms, Eye symptoms, Airway symptoms, Other, what?” Both missing 
responses (representing between 4.4 % and 7.7 % among asthmatics, and between 3.6 % and 9.3% 
among controls), and “I don´t know” responses (representing between 6.0 % and 12.5 % among 
asthmatics, and between 5.0 % and 7.7% among controls) to AR, AD and AC questions were 
regarded as “No” in the main analysis. In the complete case analysis, the “I don´t know” values and 
missing values were both regarded as missing values. 
 
Statistical analyses 
The comparisons of demographic data or allergic multimorbidity prevalence between asthma and 
control groups were performed by conditional logistic regression and were reported as odds ratios 
(OR) with 95% confidence intervals.  
The association between allergic multi-morbidity and adult-onset asthma was conducted considering 
3 consecutive allergic multimorbidity variables: (i.) ≥ 1 allergic disease (main model); (ii.) the number 
of allergic multi-morbidities to address a possible dose-response relationship; (iii.) type of allergic 
disease to test whether each allergic multimorbidity confers an asthma risk of similar magnitude. All 
models were adjusted by age, gender and living region. The models (i.-iii.) were also performed with 
adjustment on the following potential confounding factors identified in the directed-acyclic-graph 
(figure S1) : gender, age (continuous), living region, smoking (never vs. ever), growing in countryside, 
severe childhood infections (pneumonia before or during school age and/or hospitalization due to 
infection at ≤3 years of age), parental asthma/allergy, parental smoking, education level 
(baccalaureate; secondary; primary school), professional training (completed professional 
college/university; courses/completed trade school; no), number of siblings, and birth order (13,17-
20). In further analyses, 2 variables were successively tested as potential effect modifier in the 
association between ≥1 allergic multimorbidity and adult-onset asthma by adding an interaction 
term in the regression models: 1) age, considering three age categories equal in size: subjects <50 
years, 50-62 years and >62 years, following previous findings indicating that risk of adult-onset 
asthma associated with polysensitization decreases with age (12); 2) Sex, to address a sex effect in 
the association between allergic multimorbidity and adult-onset asthma, as previously suggested 
(21). In addition, the association between ≥1 allergic multimorbidity and asthma was stratified by 
the asthma severity status (mild-moderate vs. severe), to address the hypothesis that allergic 
multimorbidity could be associated with more severe asthma, as suggested in children (22).       
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Finally, sensitivity analyses were conducted to address the robustness of the results 1) to 
missingness, by including only subjects without missing data for each allergic multimorbidity 
question (missing values were a priori imputed as “No” for each allergy multimorbidity question); 2)  
to the case  and control definition, by excluding 99 subjects with potential misclassification given the 
questionnaire data (24 controls who reported using current regular asthma medication, 10  cases 
who did not report using and 65 cases who reported onset asthma before 15 years of age).   
 
P-values less than 0.05 were considered statistically significant. Statistics were performed with SPSS 
Base 24 Statistical Software Package (SPSS, Chicago, IL, USA). 
 
Results 
 
Subject characteristics 
The total number of asthma cases with available data was 1118 and matched controls was 1772 
(Table 1). The mean ± SD, min-max age of the subjects was 53±11, 31-71 years. The proportion of 
females was 63 %. The proportion of asthma cases having self-reported AR, AC or AD were 50.2 %, 
39.6 %, 33.8 %, respectively in comparison to control group 26.1 %, 20.0 %, 23.5 %, respectively 
(Table 1, Table 4). As compared to controls, asthma cases were more often ever smoker, had more 
often severe childhood infections and parental asthma/allergy, parental smoking, and had a lower 
education level and professional training (Table 1). Among asthma cases, 10% had severe asthma.  
 
At least one allergic multimorbidity and adult-onset asthma  
The presence of at least one allergic disease was associated with an increased risk for adult onset 
asthma, with an adjusted OR [CI95%] of (2.60 [2.11-3.19], Table 2). This association between adult-
onset asthma and ≥1 allergic multimorbidity was slightly higher in females than in males (2.80 [2.14-
3.66] and 2.40 [1.70-3.39], respectively), but there was no statistically significant gender difference 
(adjusted p value for interaction was 0.45, Figure 2, Table 2). Age was an effect modifier in this 
association (adjusted p value for interaction was 0.002). The odds ratio of adult-onset asthma 
associated with ≥1 allergic multimorbidity increased with decreasing age: adjusted OR [CI95%] were 
3.52 [2.51-4.94], 2.44 [1.74-3.42] and 1.68 [1.04-2.71] in subjects <50 years, 50-62 years and >62 
years, respectively (Table 2). The association was stronger in those with severe asthma, as compared 
to those with mild-moderate asthma, although the interaction term was nonsignificant (adjusted OR 
[CI95%] were 4.90 [1.95-12.32] and 2.56 [2.06-3.19], respectively) (Table 2). The sensitivity analysis 
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conducted on complete case analysis (n=1955) showed similar patterns of association and lead to 
higher adjusted OR point estimates (e.g. risk associated for ≥1 allergic disease was 3.31 [2.56-4.28], 
3.73 [2.67-5.22], 3.07 [1.97-4.78] in all, females and males respectively, and 4.58 [3.00-6.97], 3.80 
[2.41-6.00], 1.72 [0.95-3.14],  in subjects <50 years, 50-62 years and >62 years, respectively.   
 
Number of allergic diseases and adult-onset asthma  
When considering the number of allergic diseases, a dose-response relationship was observed: 
adjusted OR [CI95%] for 1, 2, and 3 allergic diseases were 1.95 [1.52-2.49], 2.87 [2.19-3.77], and 4.26 
[3.07-5.90] as compared to no allergic disease, respectively (Figure 2, Table 3, p for trend test 
<0.0001). A similar pattern of association was observed in females, with OR [CI95%] 2.08 [1.51-2.86], 
3.06 [2.18-4.30], and 4.08 [2.80-5.94], respectively and in males OR [CI95%] were 1.78 [1.18-2.68], 
2.82 [1.72-4.63], and 6.51 [2.92-14.46], respectively (p value for trend test <0.001 in males and in 
females).  In the complete case analysis adjusted OR [CI95%] were 2.27 [1.66-3.10], 3.67 [2.66-5.07], 
5.15 [3.56-7.45], respectively. Sensitivity analysis on the definition of asthma and control showed 
very similar results (Figure S2).   
 
Type of allergic multimorbidities and adult-onset asthma  
In adjusted models, all single and combined allergic diseases were significantly associated with 
higher risk of asthma with OR > 2.2 except AD only, for which the adjusted OR [CI95%] estimated 
was 1.25 [0.87-1.80] (Table 3). The association between adult-onset asthma and AC only or AR only 
was of similar magnitude (2.35 [1.48-3.71] and 2.53 [1.83-3.50], respectively, Table 3). The presence 
of all three allergic diseases (AR+AC+AD) had the strongest effect on adult-onset asthma (adjusted 
OR [CI95%] 4.19 [3.02-5.81]) (Table 3). The next strongest association with adult-onset asthma was 
observed for co-existing AR+AC, 3.04 [2.17-4.26] (Table 3). The sensitivity analysis on complete case 
analysis (n=1955) showed similar patterns of association, and tended to increase OR point estimates 
(Table S1). 
 
Discussion 
 
In this population-based case-control study we detected strong associations between allergic 
diseases and asthma diagnosis in adulthood. Our major finding was that adult-onset asthma was 
positively associated with the number of allergic diseases and this association decreases with age. 
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The strong association between allergic multimorbidity and adult-onset asthma observed in this 
study extends to adulthood observations well demonstrated in children. The association between 
asthma and allergic multimorbidity, including rhinitis, conjunctivitis, and dermatitis, is well described 
in children (3). Causal network analysis in school-aged children has shown that allergen sensitization, 
allergic inflammation, environmental tobacco smoke exposure, pulmonary physiology, and rhinitis 
severity explained over half of the variance in asthma severity (22). However, there has been limited 
knowledge of the effect of allergic multimorbidity on asthma-risk in adults. In a previous study we 
found that polysensitization was associated with asthma in adults (10). In agreement with these 
findings, here we demonstrate that allergic multimorbidity is associated with asthma diagnosed in 
adulthood. Noteworthy, we showed a dose-response relationship between the number of allergic 
multimorbidities and asthma. Therefore, our results suggest that the multimorbid approach of 
allergic diseases should consider multiple organs (nose, eye, skin and lower airways). These results 
are in accordance with previous data in adults demonstrating that the asthma-plus-rhinitis 
multimorbidity is associated with strong polysensitization and combined the sensitization pattern of 
both the AR only and asthma only phenotypes (23). These observations were recently extending by 
considering conjunctivitis in addition to rhinitis and asthma; the study showed that increase in 
allergic multimorbidity, irrespective of the disease (rhinitis, conjunctivitis and asthma) was 
associated with a significant increase in the number of IgE-reactivities to respiratory allergens (24).  
In addition, we have previously detected in a smaller adult population that allergic rhinitis and/or 
allergic conjunctivitis (AR/AC) and polysensitization co-associate with adult asthma (11).  
  
 
We found that the association between adult-onset asthma and allergic multimorbidity decreased 
with age. These findings of a stronger increase in asthma risk associated with allergic multimorbidity 
in the youngest group are in line with results from a Swedish study showing that the prevalence of 
allergic asthma has increased during the past two decades, while the prevalence of non-allergic 
asthma has remained on a stable prevalence level (9). In addition, our findings are in agreement with 
our previous observation showing that  polysensitization was associated with asthma in adults (10), 
and this association was stronger in adults who were born after 1930 (12). Altogether, these 
observations suggest that the proportion of allergic multimorbidity and allergic polysensitization 
among asthmatics is increasing with later decades of birth. To which extent this observation results 
from a cohort-effect, e.g. change in host-microbiome-environmental interactions during 
development over time, and from an ageing effect remains unknown and requires further studies 
(25). 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
 
Childhood asthma is characterized by a predominance of allergic multimorbidity in males (26). 
Pediatric studies have also shown that allergic multimorbidity and/or polysensitization associates 
with asthma persistence (27). A follow-up study including French children showed that risk factors 
for asthma persisting into of 13 years of age were allergic sensitization to multiple airborne 
allergens, initial atopic dermatitis, severe recurrent wheezing and hypereosinophilia (28).  A previous 
European population-based study has focused on atopic vs. non-atopic asthma instead of 
multimorbidity, and showed that female gender is an independent risk for non-atopic asthma (21). 
This observation was not explained by differences in smoking, obesity and diagnoses between males 
and females (21). Our study did not bring evidence of strong gender differences in the association 
between allergic multimorbidity and asthma in adulthood.  
 
Although the co-occurrence of allergic diseases and asthma is more common than expected by 
chance, particularly in children, the extent to which the allergic diseases and asthma share a 
common cause is still not fully understood. A large European GWAs on asthma and IgE showed no 
overlap between loci strongly associated with asthma and those strongly associated with IgE levels, 
except in HLA-DR (29), suggesting that the causal role of IgE in the development of asthma might be 
lower than expected. In addition, a study focusing on eczema, asthma and rhinitis multimorbidity 
showed that although IgE sensitization is associated with excess allergic multimorbidity (including 
asthma), its presence accounted for less than 40% of multimobidity, suggesting that IgE sensitization 
can no longer be considered as the dominant causal mechanism of allergic multimorbidity (30). Our 
study addressed the association between allergic multimorbidity and adult-onset asthma, which has 
less been studied. Yet it remains open, to which extent the association between allergic multi-
morbidity and asthma is a true causal association and to which it extent it relies on shared 
mechanisms between asthma and allergic diseases.  
 
Our data, including 10% of adults with severe asthma, suggest that allergic multimorbidity might be 
more strongly associated with severe asthma than milder form of asthma, although asthma severity 
was not identified as a significant modifier effect given the large confidence intervals. Our results are 
in line with results from previous publications (31). Among adult women with asthma, a clustering 
approach using drug based administrative databases identified three multimorbidity patterns 
associated with asthma, including a pattern mainly characterized by “allergic multimorbidity” that 
represented 33% of the population (31). This multimobidity profile showed an increased risk of 
subsequent uncontrolled asthma and asthma exacerbations as compared to a profile characterized 
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by “few multimorbidity” and, importantly, this risk was of similar magnitude than the risk observed 
for the “metabolic multimorbidity” profile (31). Thus, allergic diseases affect morbidity life-long (32), 
although, in terms of mortality previous studies indicate that AR/AC did not explain excess mortality 
among asthmatic adults (13). Overall, it is likely that asthma with allergic multimorbidity represent 
phenotypes that considerably differ from asthma alone in terms of mechanisms, severity and 
prognosis. More studies to prove this are needed.  
 
Strengths and limitations 
 
The strengths of the study include the large population-based design that mitigates potential for 
sampling bias, high age range and a historical aspect of subjects born in early 1900´s, and a high 
responder rate. In addition, given the detailed information recorded in the study, we were able to 
adjust for a large set of potential confounders in the analysis. Nevertheless, the association reported 
could be partly biased by residual for confounding, either due to missing potential confounders in 
the regression model (i.e. occupational exposure), or due to limited accuracy in the assessment of 
some independent variables (i.e. the smoking variable does not take into account for the amount 
and the duration of smoking), caution is needed about extrapolating our results to another 
population; the results of this study should be confirmed in other population and countries. The 
weaknesses of our study include the limited statistical power of some analysis on sub-groups, in 
particular the analysis addressing the modifying effect of asthma severity. Despite the efforts in the 
definition of cases and controls in this study, we acknowledge that few controls reported doctor-
diagnosed asthma with current asthma medication (although not fulfilling asthma diagnosis of the 
reimbursement register), and that a small portion of asthmatics might had childhood-onset asthma 
that relapsed in adulthood. However, sensitivity analyses relying on more stringent definitions of 
cases and controls using questionnaire data led to the same conclusions, indicating that our findings 
are not biased by potential misclassifications. In addition, a memory bias in the report of allergic 
diseases might have occurred, and more likely in the oldest age group, which would lead to bias 
towards the null the association in particular in the oldest age group; therefore, if such a memory 
biased occurred, it might have partly contributing in showing strongest associations in the youngest 
age group. Nevertheless, we believe that, if this bias occurred, it was of limited impact on our main 
results because subjects had the possibility to reply “I don’t know” and the complete case analysis 
that considered “I don’t know” as missing values showed similar patterns of associations with 
stronger magnitude of the effects and the age modifying effect remained significant. The cross-
sectional design does not allow assertion on the causal direction of associations, however because 
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asthma was recently diagnosed (past year) given to the study design, we might hypotheses that 
allergic multimorbities occurred before asthma on most of the cases. 
 
Conclusion 
The presence of allergic multimorbid diseases was associated with asthma diagnosed in individuals 
over 30 years of age. This association was gradually increasing with the number of allergic diseases 
and was stronger in the younger age group. Altogether our results support that allergic 
multimorbidity becomes an important concept across the life cycle. Further research on prospective 
cohorts would be needed to confirm these results.  
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Figure 1.  
Flow chart of the study population.  
Asthmatics drawn from the the Finnish Drug Reimbursement register were over 30 years old, 
recently (in 2 years) diagnosed asthmatics, that had received the right for asthma medication 
reimbursement. Two controls were drawn from National registers and were matched for gender, 
age, and living region. 
 
Figure 2.  
Forest plot summarizing the associations between allergic disease(s) and adult-onset asthma.  
Adjusted OR and 95%CI of adult-onset asthma are presented for ≥1 allergic disease (in all, by gender 
and by age group) and for the number of allergic diseases.  Models were adjusted on gender, age 
and region, smoking, growing in countryside, childhood pneumonia/hospitalization due to infection, 
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parental asthma/allergy, parental smoking, education level, professional training, number of siblings, 
and birth order. The total number of asthmatics is 930 and matched controls is 1289. 
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Table 1. Association between self-reported demographic factors and asthma diagnosis. 
 
 Control 
(n=1772) 
n (%) 
Asthma 
(N=1118) 
 n (%) 
ORa (95% CI)  
Allergic rhinitis1 
No 
Yes 
1309 (73.9) 
463 (26.1) 
557 (49.8) 
561 (50.2) 
 
1 
2.84 (2.40-3.36) 
 
Allergic conjunctivitis1 
No 
Yes 
1418 (80.0) 
354 (20.0) 
675 (60.4) 
443 (39.6) 
 
1 
2.59 (2.18-3.08) 
 
Allergic dermatitis1 
No 
Yes 
1356 (76.5) 
416 (23.5) 
740 (66.2) 
378 (33.8) 
 
1 
1.68 (1.42-2.00) 
 
Smoking 
Never 
Ever 
810 (46.7) 
925 (53.3) 
423 (38.7) 
671 (61.3) 
 
1 
1.37 (1.15-1.61) 
 
Parental asthma or allergy2
No 
Yes 
1359 (79.8) 
344 (20.2) 
689 (63.3) 
400 (36.7) 
 
1 
2.42 (2.01-2.92) 
 
Number of siblings 
0-1 
2-3 
≥ 4 
409 (23.4) 
586 (33.5) 
752 (43.0) 
248 (22.8) 
356 (32.7) 
486 (44.6) 
 
1 
1.02 (0.82-1.26) 
1.12 (0.91-1.38) 
 
Birth order 
1. 
2.-3. 
≥ 4. 
497 (28.9) 
712 (41.3) 
513 (29.8) 
316 (29.1) 
450 (41.5) 
319 (29.4) 
 
1 
0.98 (0.81-1.19) 
0.98 (0.80-1.21) 
 
Childhood exposure to maternal or paternal 
smoking 
No 
Yes 
                           
.901 (50.8) 
871 (49.2) 
                           
.536 (47.9) 
582 (52.1) 
 
1 
1.11 (0.95-1.30) 
 
Childhood spent in farm or countryside 
No 451 (25.7) 268 (24.3) 
 
1 
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Yes 1305 (74.3) 833 (75.7) 1.13 (0.94-1.37 
Severe childhood infections3
No 
Yes 
                           
1515 (87.6) 
214 (12.4) 
                           
881 (81.6) 
198 (18.4) 
 
1 
1.16 (1.31-2.04) 
 
Education level 
Baccalaureate 
Secondary school / equivalent 
 Primary school or less 
344 (19.8) 
429 (24.7) 
961 (55.4) 
156 (14.3) 
272 (25.0) 
661 (60.7) 
 
1 
1.42 (1.10-1.83) 
1.76 (1.37-2.25) 
 
Training  
Professional college /University 
Courses / Trade school 
No 
485 (29.0) 
798 (47.7) 
389 (23.3) 
239 (23.4) 
521 (51.1) 
260 (25.5) 
 
1 
1.35 (1.11-1.65) 
1.51 (1.17-1.93) 
 
Severe asthma4 - 110 (10.0) -  
Age at onset of asthma symptoms, n (%)5,6 
In childhood 
At school age 
Over 15 y of age 
In adulthood 
- 37 (3.4) 
28 (2.6) 
23 (2.1) 
992 (91.9) 
 
- 
The place of physician-diagnosed asthma, n (%)5,7
Primary care 
Hospital 
- 283 (25.6) 
822 (74.4) 
 
- 
Asthma symptoms, n (%)5,7
None to mild 
Moderate 
Severe 
- 260 23.3) 
725 (64.8) 
120 (10.7) 
 
- 
Doctor-diagnosed asthma with current asthma 
medication8  
No 
Yes 
                           
1669 (98.6) 
24 (1.4) 
                           
10 (0.9) 
1056 (99.1) 
 
1 
107.5 (63.8-181.2) 
  
1self-reported allergic disease ever, 2missing value= The subject responded that he/she does not 
have either of the asked relatives (mother or father). 3Severe childhood infections = Pneumonia 
before or during school age and/or hospitalization due to infection at ≤3 yrs of age. 4Self-reported 
severe asthma symptoms AND regular harm caused by asthma AND (≥1 peroral corticosteroid 
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course/regular corticosteroids due to asthma during the past 12 months AND/OR wake up in the 
night due to asthma at ≥1/week). 5The questions were asked only from the asthmatics. 6The number 
of missing responses from asthmatics was 38. 7The number of missing responses from asthmatics 
was 13. 8The number of missing responses from asthmatics was 52 and from nonasthmatics 79. ORa= 
odds ratio adjusted for gender, age and region. 
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Table 2. Association of ≥1 allergic disease with adult onset asthma, in the whole population and 
stratified by gender, age group and asthma severity. The reference group for OR-values are the 
controls. 
 
 
 Controls 
with ≥1 
allergic 
disease1 
n (%) 
Asthmatic
s with ≥1 
allergic 
disease1 
n (%) 
ORa (95% CI)  ORb (95% CI)  
Total  760 (42.9%) 745 
(66.6%) 
2.78 (2.35-
3.28) 
 2.60 (2.11-3.19)  
By Gender     
Females 542 (48.2) 518 (74.6) 3.08 (2.48-
3.83) 
 2.80 (2.14-3.66)  
Males  218 (33.7) 227 (53.5) 2.37 (1.82-
3.09) 
 2.40 (1.70-3.39)  
By age group     
< 50 years 350 (50.6) 353 (78.8) 3.93 (2.93-
5.34) 
 3.52 (2.51-4.94)  
50-62 years  256 (41.0) 250 (65.3) 2.65 (2.02-
3.48) 
 2.44 (1.74-3.42)  
> 62 years  154 (33.8) 142 (49.5) 1.91 (1.40-
2.62) 
 1.68 (1.04-2.71)  
By asthma 
severity status 
    
  Mild-moderate 485 (30.3) 675 (67.0) 2.73 (2.29-
3.26) 
 2.56 (2.06-3.19)  
  Severe 57 (33.7) 70 (63.6) 3.18 (1.88-
5.40) 
 4.90 (1.95-12.32)  
The total number of asthmatics is 1118 and matched controls is 1772. 
Allergic disease1= presence of at least one of the following self-reported diseases ever: allergic 
rhinitis, allergic conjunctivitis, allergic dermatitis. ORa= odds ratio adjusted for gender, age and 
region; ORb= adjusted for gender, age and region, as well as for selected covariates: smoking, 
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growing in countryside, childhood pneumonia/hospitalization due to infection, parental 
asthma/allergy, parental smoking, education level, professional training, number of siblings, and 
birth order.  
p for interaction: 
≥1 allergic disease* gender p=.13, adjusted p=.45 
≥1 allergic disease* asthma severity status p=.59, adjusted p=.72 
p for trend: ≥1 allergic disease* age p=.016, adjusted p=.002 
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Table 3. Association of different combinations of allergic diseases with adult-onset asthma.  
 Controls 
(n=1772) 
n (%) 
Asthmatics 
(n=1118) 
n (%) 
ORa (95% CI)  ORb (95% CI)  
Model 1: Number of allergic 
diseases1 
   
0 1012 (57.1) 373 (33.4) 1  1  
1 402 (22.7) 297 (26.6) 2.09 (1.71-
2.57) 
 1.95 (1.52-2.49)  
2 243 (13.7) 259 (23.2) 3.09 (2.46-
3.87) 
 2.87 (2.19-3.77)  
3 115 (6.5) 189 (16.9) 4.36 (3.32-
5.72)2 
 4.26 (3.07-5.90) 2  
Model 2: Type of allergic 
diseases1 
   
No 1012 (57.1) 373 (33.4) 1  1  
Only AR 150 (8.5) 152 (13.6) 2.78 (2.12-
3.65) 
 2.53 (1.83-3.50)  
Only AC 60 (3.4) 68 (6.1) 3.13 (2.14-
4.58) 
 2.35 (1.48-3.71)  
Only AD 192 (10.8) 77 (6.9) 1.18 (0.87-
1.59) 
 1.25 (0.87-1.80)  
AR+AC 134 (7.6) 147 (13.1) 3.00 (2.26-
3.98) 
 3.04 (2.17-4.26)  
AR+AD 64 (3.6) 73 (6.5) 3.39 (2.32-
4.94) 
 2.81 (1.81-4.35)  
AC+AD 45 (2.5) 39 (3.5) 2.50 (1.56-
4.02) 
 2.20 (1.28-3.78)  
AR+AC+AD 115 (6.5) 189 (16.9) 4.33 (3.30-
5.70)2 
 4.19 (3.02-5.81) 2  
1Allergic diseases include allergic rhinitis (AR), allergic conjunctivitis (AC), and allergic dermatitis (AD).  
ORa= odds ratio adjusted for gender, age and region; ORb= adjusted for gender, age and region, as 
well as for selected covariates: smoking, growing in countryside, childhood 
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pneumonia/hospitalization due to infection, parental asthma/allergy, parental smoking, education 
level, professional training, number of siblings, and birth order.  
2small differences in the estimates between model 1 and 2 comes from differences of estimating 
methods.  
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Table 4. Association of each allergic disease with adult onset asthma in all subjects by conditional 
logistic regression.  
 
 Controls 
(n=1772) 
n (%) 
Asthmatics 
(n=1118)  
n (%) 
ORa (95% CI)  ORb (95% CI)  
Presence of the following 
allergic diseases 
   
Model 1: AR 463 (26.1) 561 (50.2) 2.84 (2.40-
3.36) 
 2.68 (2.19-3.28)  
Model 2: AC 354 (20.0) 443 (39.6) 2.59  (2.18-
3.08) 
 2.37 (1.93-2.91)  
Model 3: AD 416 (23.5) 378 (33.8) 1.68 (1.42-
2.00) 
 1.61 (1.31-1.98)  
AR=allergic rhinitis, AC=allergic conjunctivitis, AD= allergic dermatitis. ORa= odds ratio adjusted for 
gender, age and region; ORb= adjusted for gender, age and region, as well as for selected covariates: 
smoking, growing in countryside, childhood pneumonia/hospitalization due to infection, parental 
asthma/allergy, parental smoking, education level, professional training, number of siblings, and 
birth order.  
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